Enterprise Value
39.94M
Cash
17.47M
Avg Qtr Burn
-5.974M
Short % of Float
5.21%
Insider Ownership
22.33%
Institutional Own.
9.68%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MYDCOMBI™ (trop+phen) (MicroStat) Details Eye disease | Approved Quarterly sales | |
APP13007 Details Eye disease | PDUFA Approval decision | |
MicroPine (Atropine) Details Eye disease | Phase 3 Data readout | |
MicroLine (Apersure™) Details Eye disease | Phase 3 Data readout |